Suspected limited efficacy of γ-secretase modulators

被引：10
|
作者：
Kakuda, Nobuto [1 ,2 ]
Akazawa, Kohei [3 ]
Hatsuta, Hiroyuki [4 ]
Murayama, Shigeo [4 ]
Ihara, Yasuo [1 ,2 ,5 ,6 ]
机构：
[1] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyoto 602, Japan
[2] Japan Sci & Technol Agcy, CREST, Saitama, Japan
[3] Niigata Univ, Med & Dent Hosp, Dept Med Informat, Niigata, Japan
[4] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan
[5] Doshisha Univ, Ctr Neurol Dis, Kyoto 602, Japan
[6] New Energy & Ind Technol Dev Org NEDO, Kanagawa, Japan
来源：
NEUROBIOLOGY OF AGING | 2013年 / 34卷 / 04期
关键词：
gamma-Secretase; gamma-Modulator; Alzheimer's disease; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; TRANSMEMBRANE DOMAIN; PRESENILINS; PROTEIN; TARGET;
D O I：
10.1016/j.neurobiolaging.2012.08.017
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Mild cognitive impairment and Alzheimer's disease (AD) are associated with changes in gamma-secretase activity in the brain, producing an amyloid beta-protein-42-lowering gamma-modulator-like effect. We show here that this modulation occurs at the stage of amyloid deposition, presumably decades earlier than the onset of AD. In addition, gamma-secretase modulator-1, a gamma-modulator, altered gamma-secretase activity in the AD brain but to a lesser extent than in the normal brain. These findings suggest that gamma-modulators have limited efficacy against amyloid deposition and AD. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：1101 / 1104
页数：4
相关论文
共 50 条
  • [21] Purine derivatives as potent γ-secretase modulators
    Rivkin, Alexey
    Ahearn, Sean P.
    Chichetti, Stephanie M.
    Hamblett, Christopher L.
    Garcia, Yudith
    Martinez, Michelle
    Hubbs, Jed L.
    Reutershan, Michael H.
    Daniels, Matthew H.
    Siliphaivanh, Phieng
    Otte, Karin M.
    Li, Chaomin
    Rosenau, Andrew
    Surdi, Laura M.
    Jung, Joon
    Hughes, Bethany L.
    Crispino, Jamie L.
    Nikov, George N.
    Middleton, Richard E.
    Moxham, Christopher M.
    Szewczak, Alexander A.
    Shah, Sanjiv
    Moy, Lily Y.
    Kenific, Candia M.
    Tanga, Flobert
    Cruz, Jonathan C.
    Andrade, Paula
    Angagaw, Minilik H.
    Shomer, Nirah H.
    Miller, Thomas
    Munoz, Benito
    Shearman, Mark S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2279 - 2282
  • [22] Substrate-targeting γ-secretase modulators
    Kukar, Thomas L.
    Ladd, Thomas B.
    Bann, Maralyssa A.
    Fraering, Patrick C.
    Narlawar, Rajeshwar
    Maharvi, Ghulam M.
    Healy, Brent
    Chapman, Robert
    Welzel, Alfred T.
    Price, Robert W.
    Moore, Brenda
    Rangachari, Vijayaraghavan
    Cusack, Bernadette
    Eriksen, Jason
    Jansen-West, Karen
    Verbeeck, Christophe
    Yager, Debra
    Eckman, Christopher
    Ye, Wenjuan
    Sagi, Sarah
    Cottrell, Barbara A.
    Torpey, Justin
    Rosenberry, Terrone L.
    Fauq, Abdul
    Wolfe, Michael S.
    Schmidt, Boris
    Walsh, Dominic M.
    Koo, Edward H.
    Golde, Todd E.
    NATURE, 2008, 453 (7197) : 925 - U62
  • [23] Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
    Kengo Uemura
    Katherine C. Farner
    Tadafumi Hashimoto
    Navine Nasser-Ghodsi
    Michael S. Wolfe
    Edward H. Koo
    Bradley T. Hyman
    Oksana Berezovska
    Nature Communications, 1
  • [24] Therapeutic potential of γ-secretase inhibitors and modulators
    Imbimbo, Bruno P.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (01) : 54 - 61
  • [25] Exploring the chemical space of γ-secretase modulators
    Zettl, Heiko
    Weggen, Sascha
    Schneider, Petra
    Schneider, Gisbert
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (09) : 402 - 410
  • [26] Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
    Uemura, Kengo
    Farner, Katherine C.
    Hashimoto, Tadafumi
    Nasser-Ghodsi, Navine
    Wolfe, Michael S.
    Koo, Edward H.
    Hyman, Bradley T.
    Berezovska, Oksana
    NATURE COMMUNICATIONS, 2010, 1
  • [27] γ-Secretase Processing and Effects of γ-Secretase Inhibitors and Modulators on Long Aβ Peptides in Cells
    Ran, Yong
    Cruz, Pedro E.
    Ladd, Thomas B.
    Fauq, Abdul H.
    Jung, Joo In
    Matthews, Julian
    Felsenstein, Kevin M.
    Golde, Todd E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (06) : 3276 - 3287
  • [28] Potent benzoazepinone γ-secretase modulators with improved bioavailability
    Methot, Joey L.
    Fischer, Christian
    Li, Chaomin
    Rivkin, Alexey
    Ahearn, Sean P.
    Brown, William Colby
    Kattar, Sam
    Kelley, Elizabeth
    Mampreian, Dawn M.
    Schell, Adam
    Rosenau, Andrew
    Zhou, Hua
    Ball, Richard
    Deshmukh, Sujal V.
    Jeliazkova-Mecheva, Valentina V.
    Diaz, Damaris
    Moy, Lily Y.
    Kenific, Candia M.
    Moxham, Chris
    Shah, Sanjiv
    Nuthall, Hugh
    Szewczak, Alexander A.
    Hill, Armetta
    Hughes, Bethany
    Smotrov, Nadya
    Munoz, Benito
    Miller, Thomas A.
    Shearman, Mark S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (17) : 3495 - 3500
  • [29] ?-Secretase inhibitors and modulators for Alzheimer's disease
    Wolfe, Michael S.
    JOURNAL OF NEUROCHEMISTRY, 2012, 120 : 89 - 98
  • [30] The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators
    Huang, Xianhai
    Aslanian, Robert
    Zhou, Wei
    Zhu, Xiaohong
    Qin, Jun
    Greenlee, William
    Zhu, Zhaoning
    Zhang, Lili
    Hyde, Lynn
    Chu, Inhou
    Cohen-Williams, Mary
    Palani, Anandan
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (04): : 184 - 187
12345